微創機器人-B(02252.HK):圖邁®腔鏡手術機器人獲得國家藥監局註冊批准
格隆匯1月27日丨微創機器人-B(02252.HK)發佈公吿,公司自主研發的圖邁®腔鏡手術機器人(“圖邁”)獲得國家藥品監督管理局頒發的上市註冊證,成為首款亦是截至該公吿日期唯一一款由中國企業研發並獲准上市的四臂腔鏡手術機器人。
公吿表示,圖邁是一款由集團為廣泛的外科手術而設計開發的腔鏡手術機器人,乃公司核心產品,可使用微創傷方法實現複雜的手術,其機械臂的高靈活性可以提高手術的精準度,加強手術安全性,減少外科醫生的疲憊感。外科醫生安坐於控制枱,便可觀看手術部位的沉浸式三維高清影像,並通過控制機械臂操控患者體內的手術器械,在完成一系列與人體手腕相似動作的同時,也可去除人體手部固有的震顫。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.